VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $303,615 | -13.0% | 10,084 | -6.5% | 0.04% | -18.9% |
| Q1 2023 | $349,009 | +12.8% | 10,789 | -0.0% | 0.05% | +6.0% |
| Q4 2022 | $309,286 | -1.5% | 10,792 | -17.2% | 0.05% | -16.7% |
| Q3 2022 | $314,000 | -6.0% | 13,033 | +7.0% | 0.06% | -1.6% |
| Q2 2022 | $334,000 | -29.8% | 12,183 | -1.9% | 0.06% | -23.8% |
| Q1 2022 | $476,000 | +110.6% | 12,414 | +76.1% | 0.08% | +86.0% |
| Q4 2021 | $226,000 | – | 7,050 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |